Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABALOPARATIDE for Osteoporosis postmenopausal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7,932 adverse event reports in the FDA FAERS database where ABALOPARATIDE was used for Osteoporosis postmenopausal.

Most Reported Side Effects for ABALOPARATIDE

Side Effect Reports % Deaths Hosp.
Headache 4,048 17.3% 0 92
Nausea 3,134 13.4% 1 84
Dizziness 3,005 12.9% 0 99
Fatigue 2,637 11.3% 0 63
Heart rate increased 2,092 9.0% 0 40
Palpitations 1,730 7.4% 0 50
Arthralgia 1,711 7.3% 0 41
Bone pain 1,360 5.8% 0 26
Back pain 1,229 5.3% 0 37
Pain 1,191 5.1% 0 48
Product dose omission issue 1,006 4.3% 0 78
Injection site bruising 946 4.1% 0 20
Product dose omission 938 4.0% 1 64
Product quality issue 914 3.9% 1 26
Pain in extremity 912 3.9% 0 26

Other Indications for ABALOPARATIDE

Senile osteoporosis (7,272) Osteoporosis (4,420) Product used for unknown indication (3,174) Osteoporotic fracture (658) Pathological fracture (191) Illness (179) Rheumatoid arthritis (130) Osteoarthritis (71) Bone density abnormal (70) Bone disorder (59)

Other Drugs Used for Osteoporosis postmenopausal

DENOSUMAB (18,350) PROLIA (1,775) ROMOSOZUMAB-AQQG (1,401) TERIPARATIDE (263) ALENDRONATE (262) ZOLEDRONIC ACID (225) ALENDRONATE\CHOLECALCIFEROL (135) IBANDRONIC ACID (116) ALENDRONIC ACID (105) RISEDRONATE (105)

Related Pages

ABALOPARATIDE Full Profile All Osteoporosis postmenopausal Drugs ABALOPARATIDE Demographics ABALOPARATIDE Timeline